🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This first-in-human open-label, multi center, dose-escalation and expansion...
Status
Terminated
Location
Liverpool Hospital
Start Date
2021-10-29
Trial ID
NCT05073484
to Compare the Pharmacokinetics and Safety of BAT3306 versus KEYTRUDA® Admi...
Status
Completed
Location
Union Hospital,Tong Ji Medical College,Huazhong University of Science and Technology
Start Date
2023-11-05
Trial ID
NCT06111196
This study is a randomized, double-Blind,international multi-Centre, phase ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2020-04-17
Trial ID
NCT04301739
Treatments Being Tested
This trial is a single-center, prospective, single-arm Phase II clinical st...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-05-13
Trial ID
NCT04848597
Treatments Being Tested
This phase Ib study evaluates the safety and efficacy of OH2 in combination...
Status
Recruiting
Location
Peking University Cancer Hospital
Start Date
2020-12-01
Trial ID
NCT04616443
Treatments Being Tested
This study is a single-arm, multicenter, Phase II study to evaluate the eff...
Status
Unknown
Location
Harbin Medical University Cancer Hospital
Start Date
2022-10-01
Trial ID
NCT05444374
Treatments Being Tested
Phase II study: a study to explore the safety and preliminary efficacy of B...
Status
Recruiting
Location
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
Start Date
2023-12-13
Trial ID
NCT06123884
To evaluate the safety and tolerability of IBI3005 combination therapy in p...
Status
Not Yet Recruiting
Location
SunYat-sen University Cancer Center
Start Date
2026-06-01
Trial ID
NCT07612137
Treatments Being Tested
This phase II, multicenter, single-arm, open-label study evaluates first-li...
Status
Not Yet Recruiting
Location
West China Hospital, Chengdu, Sichuan 610000
Start Date
2026-08
Trial ID
NCT07715565
Treatments Being Tested
The primary objective is to assess the safety and tolerability of TAB004 as...
Status
Unknown
Location
University of Alabama at Birmingham
Start Date
2019-10-30
Trial ID
NCT04137900
Treatments Being Tested